Disease Ontology: Improvements for Clinical Care and Research ApplicationsLynn Schriml
Human Disease Ontology, www.disease-ontology.org
Standardized descriptions of human disease that improve capture and communication of health-related data across biomedical resources.
SILS 2015 - Connecting Precision Medicine to Precision Wellness Sherbrooke Innopole
By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Disease Ontology: Improvements for Clinical Care and Research ApplicationsLynn Schriml
Human Disease Ontology, www.disease-ontology.org
Standardized descriptions of human disease that improve capture and communication of health-related data across biomedical resources.
SILS 2015 - Connecting Precision Medicine to Precision Wellness Sherbrooke Innopole
By: Joel Dudley, Mount Sinai School of Medicine
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
FDA NGS and Big Data Conference September 2014Warren Kibbe
Presentation for the FDA NGS and Big Data Conference September 2014 held on the NIH campus. NCI initiatives, including Cancer Genomics Data Commons, NCI Cloud Pilots, big data issues for cancer
Researchers to Investigate Protein’s Role in Lung CancerLindsay Rosenwald
A grant of $1.8 million from the National Institutes of Health (NIH) will allow researchers at the Rutgers Cancer Institute of New Jersey to investigate a link between the protein Sox9 and lung cancer. Previously, the protein was shown to be an important part of the biological machinery that controls genetic activation, making it potentially a key part of the metastasis of lung cancer. It has also been linked with low rates of lung-cancer survival.
Characteristics of cases with unknown stage prostate cancerCancer Council NSW
Stage of cancer at diagnosis (e.g. localised, regional involvement, metastatic) is an important predictor of survival. This paper identifies there is cause for concern surrounding the 40% of "unknown" or unrecorded stage of diagnosis on prostate cancer patient records in NSW. This means crucial information is missing from their records. The second stage of this project, scheduled for completion in late 2014, is to identify the reasons for these missing data. Once this has been completed we can inform policy makers to ensure the data completeness can be improved. Studies using cancer staging data can then increase in quality and quantity.
Inside you will find:
* 8 Australians a day saved from cancer: Over 61,000 Australian lives have been saved by improvements in cancer prevention, screening and greatment over the past 20 years
* CLEAR Study: What might happen next with the data we've collected
* Our achievements: The results of our cancer resarch over the past 20 years
* Annual resarch awards: New research projects that were awarded funding
* Join a Research Study - Make yourself available for research and help reduce the burden of cancer
Radiotherapy and Immunotherapy Improve Metastatic Lung Cancer OutcomesLaura Lyn Jacimore
A radiation oncologist, Laura Lyn Jacimore works at UNC Nash Health Care System in Rocky Mount, North Carolina, where she consults with physicians to administer radiotherapy treatments to people with cancer. Laura Lyn Jacimore is also a member of the American Society of Therapeutic Radiation Oncology (ASTRO), and regularly attends its annual meetings.
Cancer Council NSW Research Report Newsletter - November 2013Cancer Council NSW
Inside you will find:
Forgotten cancers: Bringing research funds and resources to bear on this area
Our Staff: 5 minutes with Dr Lini Nair-Shalliker
Our Insight: TA small change to the Death Registration Notice could save lives
Research Discovery: How cancer cells learn to resist the drug treatments
Join a Research Study - Make yourself available for research and help reduce the burden of cancer by completing a 5 minute questionnaire.
Colorectal cancer screening and subsequent incidence of colorectal cancer: re...Cancer Council NSW
Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
Annika Steffen, Marianne F Weber, David M Roder and Emily Banks
FDA NGS and Big Data Conference September 2014Warren Kibbe
Presentation for the FDA NGS and Big Data Conference September 2014 held on the NIH campus. NCI initiatives, including Cancer Genomics Data Commons, NCI Cloud Pilots, big data issues for cancer
Researchers to Investigate Protein’s Role in Lung CancerLindsay Rosenwald
A grant of $1.8 million from the National Institutes of Health (NIH) will allow researchers at the Rutgers Cancer Institute of New Jersey to investigate a link between the protein Sox9 and lung cancer. Previously, the protein was shown to be an important part of the biological machinery that controls genetic activation, making it potentially a key part of the metastasis of lung cancer. It has also been linked with low rates of lung-cancer survival.
Characteristics of cases with unknown stage prostate cancerCancer Council NSW
Stage of cancer at diagnosis (e.g. localised, regional involvement, metastatic) is an important predictor of survival. This paper identifies there is cause for concern surrounding the 40% of "unknown" or unrecorded stage of diagnosis on prostate cancer patient records in NSW. This means crucial information is missing from their records. The second stage of this project, scheduled for completion in late 2014, is to identify the reasons for these missing data. Once this has been completed we can inform policy makers to ensure the data completeness can be improved. Studies using cancer staging data can then increase in quality and quantity.
Inside you will find:
* 8 Australians a day saved from cancer: Over 61,000 Australian lives have been saved by improvements in cancer prevention, screening and greatment over the past 20 years
* CLEAR Study: What might happen next with the data we've collected
* Our achievements: The results of our cancer resarch over the past 20 years
* Annual resarch awards: New research projects that were awarded funding
* Join a Research Study - Make yourself available for research and help reduce the burden of cancer
Radiotherapy and Immunotherapy Improve Metastatic Lung Cancer OutcomesLaura Lyn Jacimore
A radiation oncologist, Laura Lyn Jacimore works at UNC Nash Health Care System in Rocky Mount, North Carolina, where she consults with physicians to administer radiotherapy treatments to people with cancer. Laura Lyn Jacimore is also a member of the American Society of Therapeutic Radiation Oncology (ASTRO), and regularly attends its annual meetings.
Cancer Council NSW Research Report Newsletter - November 2013Cancer Council NSW
Inside you will find:
Forgotten cancers: Bringing research funds and resources to bear on this area
Our Staff: 5 minutes with Dr Lini Nair-Shalliker
Our Insight: TA small change to the Death Registration Notice could save lives
Research Discovery: How cancer cells learn to resist the drug treatments
Join a Research Study - Make yourself available for research and help reduce the burden of cancer by completing a 5 minute questionnaire.
Colorectal cancer screening and subsequent incidence of colorectal cancer: re...Cancer Council NSW
Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
Annika Steffen, Marianne F Weber, David M Roder and Emily Banks
Feature story from the Garvan Institute of Medical Research's April 2013 issue of Breakthrough newsletter. More at https://www.garvan.org.au/news-events/newsletters
Diagnosed with breast cancer while on a family historyscreen.docxduketjoy27252
Diagnosed with breast cancer while on a family history
screening programme: an exploratory qualitative study
A. CLEMENTS, bsc, senior research nurse, Cancer Research UK Primary Care Education Research Group,
University of Oxford, Department of Primary Health Care, Oxford, B.J. HENDERSON, phd, research psycholo-
gist, Institute of Medical & Social Care Research, Ardudwy, Normal Site, University of Wales, Bangor, Gwynedd,
S. TYNDEL, ba, research officer, Cancer Research UK Primary Care Education Research Group, University of
Oxford, Department of Primary Health Care, Oxford, G. EVANS, md frcp, consultant in medical genetics,
Department of Clinical Genetics, St Mary’s Hospital, Manchester, K. BRAIN, phd, senior research fellow,
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, J. AUSTOKER, phd,
director, Cancer Research UK Primary Care Education Research Group, University of Oxford, Department of
Primary Health Care, Oxford, & E. WATSON, phd, deputy director, Cancer Research UK Primary Care Educa-
tion Research Group, University of Oxford, Department of Primary Health Care, Oxford, UK for the PIMMS Study
Management Group*
CLEMENTS A., HENDERSON B.J., TYNDEL S., EVANS G., BRAIN K., AUSTOKER J. & WATSON E. FOR
THE PIMMS STUDY MANAGEMENT GROUP (2008) European Journal of Cancer Care 17, 245–252
Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study
Mammographic screening is offered to many women under 50 in the UK who are at moderate or high risk of
developing breast cancer because of their family history of the disease. Little is understood about the impact
of screening on the emotional well-being of women with a family history of breast cancer. This qualitative
study explores the value that women at increased risk placed on screening, both pre- and post-cancer diagnosis
and the impact of the diagnosis. In-depth interviews were undertaken with 12 women, aged 35–50, diagnosed
with breast cancer while on an annual mammographic screening programme. Women described the strong
sense of reassurance gained from screening prior to diagnosis. This faith in screening was reinforced by early
detection of their cancer. Reactions to diagnosis ranged from devastation to relief at having finally developed
a long-expected condition. Despite their positive attitudes about screening, not all women wanted to continue
with surveillance. For some, prophylactic mastectomy was preferable, to reduce future cancer risk and to
alleviate anxieties about the detection of another cancer at each subsequent screen. This study illustrates the
positive yet diverse attitudes towards mammographic screening in this group of women with a family history
of breast cancer.
Keywords: breast cancer, early screening programme, family history, qualitative.
Correspondence address: Alison Clements, Cancer Research UK Primary Care Education Research Group, University of Oxford, Department of Pr.
Diagnosed with breast cancer while on a family historyscreen.docxlynettearnold46882
Diagnosed with breast cancer while on a family history
screening programme: an exploratory qualitative study
A. CLEMENTS, bsc, senior research nurse, Cancer Research UK Primary Care Education Research Group,
University of Oxford, Department of Primary Health Care, Oxford, B.J. HENDERSON, phd, research psycholo-
gist, Institute of Medical & Social Care Research, Ardudwy, Normal Site, University of Wales, Bangor, Gwynedd,
S. TYNDEL, ba, research officer, Cancer Research UK Primary Care Education Research Group, University of
Oxford, Department of Primary Health Care, Oxford, G. EVANS, md frcp, consultant in medical genetics,
Department of Clinical Genetics, St Mary’s Hospital, Manchester, K. BRAIN, phd, senior research fellow,
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, J. AUSTOKER, phd,
director, Cancer Research UK Primary Care Education Research Group, University of Oxford, Department of
Primary Health Care, Oxford, & E. WATSON, phd, deputy director, Cancer Research UK Primary Care Educa-
tion Research Group, University of Oxford, Department of Primary Health Care, Oxford, UK for the PIMMS Study
Management Group*
CLEMENTS A., HENDERSON B.J., TYNDEL S., EVANS G., BRAIN K., AUSTOKER J. & WATSON E. FOR
THE PIMMS STUDY MANAGEMENT GROUP (2008) European Journal of Cancer Care 17, 245–252
Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study
Mammographic screening is offered to many women under 50 in the UK who are at moderate or high risk of
developing breast cancer because of their family history of the disease. Little is understood about the impact
of screening on the emotional well-being of women with a family history of breast cancer. This qualitative
study explores the value that women at increased risk placed on screening, both pre- and post-cancer diagnosis
and the impact of the diagnosis. In-depth interviews were undertaken with 12 women, aged 35–50, diagnosed
with breast cancer while on an annual mammographic screening programme. Women described the strong
sense of reassurance gained from screening prior to diagnosis. This faith in screening was reinforced by early
detection of their cancer. Reactions to diagnosis ranged from devastation to relief at having finally developed
a long-expected condition. Despite their positive attitudes about screening, not all women wanted to continue
with surveillance. For some, prophylactic mastectomy was preferable, to reduce future cancer risk and to
alleviate anxieties about the detection of another cancer at each subsequent screen. This study illustrates the
positive yet diverse attitudes towards mammographic screening in this group of women with a family history
of breast cancer.
Keywords: breast cancer, early screening programme, family history, qualitative.
Correspondence address: Alison Clements, Cancer Research UK Primary Care Education Research Group, University of Oxford, Department of Pr.
Fishbone Diagram Template
Name: Cause Effect
To complete click on grey box and type.
People
Environment
Methods
Equipment
Materials
How to develop your cause and effect diagram: 1. Identify practice problem you are trying to improve in the effect box. 2. In each category of causes, (a) people, (b) environment, (c) materials, (d) methods, and (e) equipment input causes for the effect. (See example and rubric).
8/19/2019 VERSION A
Template: Failure Modes and Effects Analysis
Step in Process
Failure
Mode
Failure Cause
Failure Effect
Occurrence Likelihood
Detection
Likelihood
Severity
Risk Profile Number
Actions to Mitigate Risk
Occurrence Likelihood rate 1-10 (10 means most likely to occur)
Detection Likelihood rate 1-10 (10 means least likely to be detected)
Severity rate 1-10 (10 means most likely to cause severe harm)
To calculate Risk Profile Number: Multiply Occurrence Likelihood times Detection Likelihood times Severity = Risk Profile Number
Submit completed FMEA form to assignment link for grading, place on presentation slide, and summarize FMEA findings in your presentation slide. (see Practice Problem Analysis Guidelines and Rubric)
9/12/2019 Version
8
Esophageal cancer and smoking
Name
Chamberlin University
PICOT Question
Are men 45 years of age and older (P) who have a one-year history of smoking or less (I) at an increased risk of developing esophageal cancer (O) compared with men age 45 and older (P) who have no smoking history (C)?
Evidence Synthesis of Literature to Address Practice Problem
According to the Cancer Research UK (2020), cancer of the esophagus is more common in older people. Around 40% of the members of the population develop esophageal cancer at the age of 75 and above. The Cancer Research UK (2020) equally notes that an estimated lifetime risk of being diagnosed with esophageal cancer us 2% for males and 1% for females in the United Kingdom. The findings of the Cancer Research UK (2020) indicate that 59% of esophageal cancer cases are preventable, but the condition is associated with a number of risk factors such as tobacco smoking, alcohol intake, and radiation exposure among other risk factors.
According to a cohort study conducted by Fan et al. (2008), tobacco smoking and alcohol consumption were established as the major risk factors for esophageal squamous cell carcinoma (ESCC), especially in the western population. The study reports many retrospective studies that have demonstrated a synergic effect of alcohol and smoking in ESCC risk. Nevertheless, prospective studies on esophageal cancer especially in high incidence regions are scare and their results have been inconsistent. Fan et al. (2008) equally reports ...
Perchloroethylene and cancer risk in Cape Cod, MAEmmett Madeson
My research delved into the possibility that perchlorethylene (PCE), and other volatile organic compounds (VOCs), spilled from the Joint Base of Cape Cod (previously known as Massachusetts Military Reservation, Otis Air National Guard Base) into the groundwater of upper Cape Cod, may be contributing to the area’s elevated breast cancer rates.
Results demonstrate that the longer a woman lives on Cape Cod, the higher her risk for breast cancer. Significant breast cancer clusters appear around groundwater plumes known to be contaminated by VOCs, and remain even after adjustments for confounding factors. Results also show that one of the contaminated plumes drains into Ashumet Pond, where the catfish also have tumorous growths not seen in fish of the same species living in ponds with VOC levels within acceptable limits.
Though the Air National Guard has made attempts at cleaning up the toxic waste, it has not addressed that their careless disposal of the waste caused up to 2,000 otherwise healthy women to develop breast cancer, with many still in the latent period. It is an injustice to the victims to make haphazard attempts to clean up the toxic waste with no apology or reparations given.
World’s First Saliva Test Detects Hidden Throat CancerAPRN World
According to American Society of Clinical Oncology, there is an estimated 53,260 adults (38,330 men and 14,880 women) in the United States will be diagnosed with oral and oropharyngeal cancer in the year 2020. Rates of these cancers are more than twice as high in men as in women. Oral and oropharyngeal cancer are the eighth most common cancer among men. The average age of diagnosis is 62. About 25% of cases occur in people younger than 55, but these cancers are rare in children.
Learn More - https://aprnworld.com/worlds-first-saliva-test-detects-hidden-throat-cancer/
Exhaled Breath Analysis for Cancer Diagnosis and Screening_Crimson PublishersCrimsonpublishersCancer
Nowadays, cancer is still one of the main fatal disorders in the world, from which the patients suffer a lot while the burden of the families and society increased. Early recognition and treatment are crucial to reduce the death rate; however, in clinical practice, many cancers could only be recognized when it comes to a later stage. With the development and progress of the modern medical technique, more and more novel testing methods are reported and under research. Many reports showed that dogs could smell out the cancer patients, and exhaled breath test with such as the gas sensor is gradually taking an important role in cancer early diagnosis and screening. However, systematic reviews in both fields are lacking.
Similar to Inherited genes make Asian women more susceptible to lung cancer - Hartford wellness (20)
Exhaled Breath Analysis for Cancer Diagnosis and Screening_Crimson Publishers
Inherited genes make Asian women more susceptible to lung cancer - Hartford wellness
1. Inherited genes make Asian women more susceptible to lung
cancer - Hartford wellness
An international group of scientists including members of the National Cancer (part of the National
Institutes of Health) recently partnered to form the Female Lung Cancer Consortium to conduct one
of the largest genome-wide association studies (GWAS) in female never-smokers to date.
According to the NCI, "lung cancer in never-smokers is the seventh leading cause of cancer deaths
worldwide, with the majority of cases historically diagnosed among women in Eastern Asia."
Although environmental factors, such as secondhand smoke (aka environmental tobacco smoke) or
exhaust from indoor cooking accounted for some cases of lung cancer among Asian women who have
never smoked, scientists involved in the study found that numerous other cases of the disease may
be caused by certain unique inherited genetic characteristics inherent in the Asian women that
distinguish it from lung cancer in smokers.
In fact, the consortium discovered that variations at three locations in the genome (two on
chromosome 6 and one on chromosome 10) were associated with lung cancer in Asian female never-
smokers. The discovery on chromosome 10 was particularly significant because it has not been
found in any other GWAS of lung cancer in white or Asian populations.
However, the researchers did not detect an association with variations at a location on chromosome
15 that has been associated with lung cancer risk in many previous GWAS of lung cancer in
smokers, leading them to conclude that "the absence of this association provides further support for
the suggestion that the genetic variation on chromosome 15 may be smoking-related,"stated Quing
Lan , M.D., Ph.D., a senior investigator in NCI's Division of Cancer Epidemiology and Genetics, and
the leader of the study.
Results for the study were based on data combined from 14 studies involving approximately 14,000
Asian women (6,600 with lung cancer and 7,500 without lung cancer), including information
regarding environmental factors, including exposure to secondhand smoke.
"This study is an example of how genome-wide association susceptibility studies can evaluate
inherited genetic risk in populations with unique characteristics or environmental exposures," stated
Dr. Stephen J. Chanock, acting co-director of NCI's Center for Cancer Genomics and a co-author of
the study. "We will continue to develop better, smarter applications of this technique and apply them
to populations where we have detailed information on environmental factors to further our
understanding of how inherited genetic factors modify risk from environmental exposures."
Readers can find more details regarding the study online the Nov.11, 2012, issue of Nature
Genetics.